Likewise, it has been demonstrated that the Trp metabolizing enzyme tryptophan 2,3-dioxygenase (TDO) inhibits the anti-tumor activity of CD8 T cells in TNBC [58]. This evidence concerns the gene CD8A and neoplasm.